46 related articles for article (PubMed ID: 8725730)
21. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
[TBL] [Abstract][Full Text] [Related]
22. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
24. [Treatment after myocardial infarction. Is rapid administration of t-PA + heparin most effective?].
Wirschubsky Z
Lakartidningen; 1993 Jun; 90(23):2240. PubMed ID: 8502089
[No Abstract] [Full Text] [Related]
25. Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.
Gautier S; Ouk T; Petrault O; Caron J; Bordet R
Br J Pharmacol; 2009 Feb; 156(4):673-9. PubMed ID: 19210512
[TBL] [Abstract][Full Text] [Related]
26. The use of proteases as thrombolytic agents from the toxicological point of view.
Klöcking HP; Sedlarik K; Hentschel H
Pol J Pharmacol Pharm; 1980; 32(2):231-5. PubMed ID: 7005879
[TBL] [Abstract][Full Text] [Related]
27. A novel approach for delivery of enzyme drugs: preliminary demonstration of feasibility and utility in vitro.
Liang JF; Li YT; Yang VC
Int J Pharm; 2000 Jul; 202(1-2):11-20. PubMed ID: 10915922
[TBL] [Abstract][Full Text] [Related]
28. [The use of the ICh-6 and ICh-7 analog frequency meters for measuring the EEG average freqiemcy].
Voĭtinskiĭ EIa; Prianishnikov VA
Biull Eksp Biol Med; 1966 Feb; 61(2):114-6. PubMed ID: 6004435
[No Abstract] [Full Text] [Related]
29. Surgery for ICH after MISTIE III.
Mitchell P; Gregson B
Br J Neurosurg; 2019 Apr; 33(2):117-118. PubMed ID: 30908083
[No Abstract] [Full Text] [Related]
30. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
Massel D
Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
[TBL] [Abstract][Full Text] [Related]
31. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.
Zenz W; Arlt F; Sodia S; Berghold A
Semin Thromb Hemost; 1997; 23(3):321-32. PubMed ID: 9255912
[TBL] [Abstract][Full Text] [Related]
32. An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.
Paoni NF; Steinmetz HG; Gillett N; Refino CJ; Badillo JM; Bunting S
Thromb Haemost; 1996 May; 75(5):820-6. PubMed ID: 8725730
[TBL] [Abstract][Full Text] [Related]
33. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
34. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
35. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
Absher PM; Hendley E; Jaworski DM; Taatjes DJ; Sobel BE
Coron Artery Dis; 1999 Sep; 10(6):413-20. PubMed ID: 10474793
[TBL] [Abstract][Full Text] [Related]
36. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
